11-114522431-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001395504.1(NXPE1):c.1181C>T(p.Thr394Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001395504.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NXPE1 | NM_001395504.1 | c.1181C>T | p.Thr394Ile | missense_variant | 9/9 | ENST00000534921.3 | NP_001382433.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NXPE1 | ENST00000534921.3 | c.1181C>T | p.Thr394Ile | missense_variant | 9/9 | 3 | NM_001395504.1 | ENSP00000439503.2 | ||
NXPE1 | ENST00000251921.6 | c.755C>T | p.Thr252Ile | missense_variant | 6/6 | 1 | ENSP00000251921.2 | |||
NXPE1 | ENST00000536271.5 | n.1573C>T | non_coding_transcript_exon_variant | 4/4 | 1 | |||||
NXPE1 | ENST00000696071.1 | c.1181C>T | p.Thr394Ile | missense_variant | 8/8 | ENSP00000512373.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250818Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135534
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461616Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727070
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74312
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at